Patient Survey
CARI Health is developing a remote medication monitor that measures methadone levels in real
time to enable more flexible take home policies and inform dose change decisions for Opioid
Treatment Providers (OTPs). The small, quarter-sized, painless sensor is attached to the body,
covered by clothing, and detects the medication in the fluid right underneath the skin. It works
similarly to the way continuous glucose monitors (CGMs) work for monitoring glucose levels. In
addition to more flexible take homes benefits include:
• improved adherence to harm reduction treatment plan
• reminders from your counselor after missing a dose to keep you on your treatment plan
• personalized dosing aligned with metabolism, drug-drug interactions, and opioid tolerance levels
Additional details about the solution:
• Overall goal is to support patients in the recovery journey, not to police
• Monitor will ONLY measure methadone levels, it is NOT a general drug screening device
• Monitor will be sweat and water resistant so it can be worn in the shower and during exercise
• Monitor is going through FDA clearance so it will be deemed safe to use
• Sensors will be replaced every 7 days either in the clinic or at home.
• Eventually it will be Medicaid reimbursed, but when it first launches it may be self-pay
